» Articles » PMID: 29348629

The Suppressive Role of Calcium Sensing Receptor in Endometrial Cancer

Overview
Journal Sci Rep
Specialty Science
Date 2018 Jan 20
PMID 29348629
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Studies have shown that calcium sensing receptor (CaSR) is involved in the progressions of several human cancers. However, the role of CaSR in endometrial cancer remains unknown. This study provides a preliminary analysis of the CaSR effect on endometrial cancer development. Ectopic CaSR expression by lentiviral transfection (CaSR-OV) in Ishikawa cells significantly increased intracellular calcium ([Ca]) levels and cell apoptosis. E-cadherin and β-catenin expression and complex formation at the membrane were increased in CaSR-OV Ishikawa cells relative to control Ishikawa cells (vector). Furthermore, CaSR-OV Ishikawa cells showed a reduced invasive potential, which was attributed to E-cadherin/β-catenin complex formation. Moreover, a reduction in CaSR expression in endometrial cancer relative to normal specimens was evident by immunohistochemistry and was positively associated with E-cadherin, but not β-catenin, expression. Furthermore, VEGFR3 was significantly down-regulated in CaSR-OV Ishikawa cells. Additionally, an immunohistochemical analysis showed that VEGFR3 was significantly increased in endometrial cancer compared with the normal endometrium and was inversely correlated with CaSR expression. However, the CaSR knockdown produced the opposite effects. These findings suggest an inhibitory role for CaSR in endometrial cancer. Therefore, reduced CaSR expression may be a suitable explanation and valuable predictor for endometrial cancer progression.

Citing Articles

Calcium and calcium-related proteins in endometrial cancer: opportunities for pharmacological intervention.

Huang T, Zhou J, Wang J Int J Biol Sci. 2022; 18(3):1065-1078.

PMID: 35173539 PMC: 8771838. DOI: 10.7150/ijbs.68591.


Calcium Sensing Receptor Inhibits Growth of Human Lung Adenocarcinoma Possibly via the GSK3β/Cyclin D1 Pathway.

Li J, Liao P, Wang K, Miao Z, Xiao R, Zhu L Front Cell Dev Biol. 2020; 8:446.

PMID: 32671062 PMC: 7330125. DOI: 10.3389/fcell.2020.00446.


Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3.

Hsu M, Pan M, Hung W Cells. 2019; 8(3).

PMID: 30901976 PMC: 6468620. DOI: 10.3390/cells8030270.


Calcium-sensing receptor in colorectal inflammation and cancer: Current insights and future perspectives.

Iamartino L, Elajnaf T, Kallay E, Schepelmann M World J Gastroenterol. 2018; 24(36):4119-4131.

PMID: 30271078 PMC: 6158479. DOI: 10.3748/wjg.v24.i36.4119.


Chemoresistance and targeting of growth factors/cytokines signalling pathways: towards the development of effective therapeutic strategy for endometrial cancer.

Guo F, Zhang H, Jia Z, Cui M, Tian J Am J Cancer Res. 2018; 8(7):1317-1331.

PMID: 30094104 PMC: 6079151.

References
1.
Zhang J, Zhou J, Cai L, Lu Y, Wang T, Zhu L . Extracellular calcium-sensing receptor is critical in hypoxic pulmonary vasoconstriction. Antioxid Redox Signal. 2011; 17(3):471-84. DOI: 10.1089/ars.2011.4168. View

2.
Kyo S, Kato K . Endometrial Cancer Stem Cell as a Potential Therapeutic Target. Semin Reprod Med. 2015; 33(5):341-9. DOI: 10.1055/s-0035-1563407. View

3.
Hua T, Liu S, Xin X, Cai L, Shi R, Chi S . S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation. Oncol Rep. 2016; 35(6):3419-26. DOI: 10.3892/or.2016.4760. View

4.
Hiani Y, Ahidouch A, Lehenkyi V, Hague F, Gouilleux F, Mentaverri R . Extracellular signal-regulated kinases 1 and 2 and TRPC1 channels are required for calcium-sensing receptor-stimulated MCF-7 breast cancer cell proliferation. Cell Physiol Biochem. 2009; 23(4-6):335-46. DOI: 10.1159/000218179. View

5.
Chakrabarty S, Wang H, Canaff L, Hendy G, Appelman H, Varani J . Calcium sensing receptor in human colon carcinoma: interaction with Ca(2+) and 1,25-dihydroxyvitamin D(3). Cancer Res. 2005; 65(2):493-8. View